Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration

Am J Ophthalmol. 2016 Jun:166:205. doi: 10.1016/j.ajo.2016.03.026. Epub 2016 Apr 16.

Authors

Mahyar Etminan¹, David A Maberley¹, David W Babiuk¹, Bruce C Carleton¹

Affiliation

¹ Vancouver, Canada.

PMID: 27093892
DOI: 10.1016/j.ajo.2016.03.026

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiogenesis Inhibitors
Bevacizumab*
Humans
Intravitreal Injections
Macular Degeneration*
Myocardial Infarction
Stroke
Vascular Endothelial Growth Factor A

Substances

Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A
Bevacizumab